Glide Pharma successfully concluded its 2nd clinical study using the Octreotide model drug to demonstrate bioequivalence of Glide solid injection with the needle and syringe administration of a liquid formulation.
Glide Pharma successfully concluded its 2nd clinical study using the Octreotide model drug to demonstrate bioequivalence of Glide solid injection with the needle and syringe administration of a liquid formulation.
